Our study indicated that age, ApoE ε4 status, higher-levels of Aβ1–42 in plasma NDEs and lower SS-16 scores predicted the AD dementia conversion in individuals with MCI patients with modest accuracy. The gene discussed is APOE; the disease is Alzheimer disease.